Datuk Zulkarnain Md Eusope, group managing director of Pharmaniaga, said that Pharmaniaga Sdn Bhd will soon commence supplying Sinovac Covid-19 booster doses to specified private hospitals and clinics, following the Drug Control Authority’s conditional approval on Wednesday (Nov 17).
Pharmaniaga Will Supply Sinovac Booster Vaccines On The Private Market
Pharmaniaga Sdn Bhd will soon commence supplying Sinovac Covid-19 booster doses to specified private hospitals and clinics, following the Drug Control Authority’s conditional approval on Wednesday (Nov 17).
Datuk Zulkarnain Md Eusope, group managing director of Pharmaniaga, said the vaccine would be accessible at selected private hospitals and clinics as an option to those that prefer the Sinovac Covid-19 vaccination booster dose.
“We hope with this effort, we can see our country revive its economy and help Malaysians weather the Covid-19 pandemic, thus ensuring the people’s wellbeing, business continuity and most importantly, saving lives,” he mentioned in a statement on Thursday (Nov 18).
Zulkarnain stated that the Sinovac booster is approved for individuals aged 18 years and older who have already received the same type of vaccination (homologous) and will be administered three to six months after the second dose, as recommended by the Covid-19 Immunisation Task Force – Booster (CITF-B).
He highlighted that a number of Chinese provinces and localities have begun administering booster doses of the Covid-19 vaccination to those who had their full doses at least six months ago.
“In China, the booster shot rollout comes after close to 80% of the population has been vaccinated, to give optimum protection against the virus and new variants.”
“According to research in China, a booster shot given at an interval of six to 12 months after the second dose led to a strong boost in immune response, with geometric mean titers (GMTs) increasing to approximately 140 in adults and even higher in the elderly aged above 60 years,” he said.
(GMTs are a measure of the detection of antibodies in an individual’s blood.)
source - harian metro
He said that the GMT six months after the third dose is greater than the peak of the second dose, and that studies have also shown a 20-fold increase in antibody persistence six months after the booster dose compared to the second dose.
This meant that protection against Covid-19 and new variants would last longer, he noted.
“Sinovac Covid-19 vaccine is safe as it is developed using inactivated virus which is a well-established technology (for) more than 40 years that is also being used commonly in many types of vaccines, currently available in the market including for polio, Hepatitis A and rabies,” he said.